Metrikler
Yayın
95
Açık Erişim
3
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2009 - 2013
2009 - 2013Tıpta Yandal Uzmanlık
İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
2003 - 2008
2003 - 2008Tıpta Uzmanlık
Diğer (Kurumlar,hastaneler Vb.), Şişli Etfal Eğitim ve Araştırma Hastanesi, Şişli Etfal Eğitim ve Araştırma Hastanesi, Türkiye
1996 - 2002
1996 - 2002Lisans
İstanbul Üniversitesi-Cerrahpaşa, Cerrahpaşa Tıp Fakültesi, Türkiye
Araştırma Alanları
Sağlık Bilimleri
Akademi Dışı Deneyim
2013 - Devam Ediyor
2013 - Devam EdiyorGASTROENTEROLOJİ UZMANI
İSTANBUL HASEKİ EĞİTİM VE ARAŞTIRMA HASTANESİ, GASTROENTEROLOJİ UZMANI
2003 - 2008
2003 - 2008İÇ HASTALIKLARI ASİSTANI
İSTANBUL ŞİŞLİ ETFAL EĞİTİM VE ARAŞTIRMA HASTANESİ, İÇ HASTALIKLARI ASİSTANI
Makaleler
Tümü (61)
SCI-E, SSCI, AHCI (48)
SCI-E, SSCI, AHCI, ESCI (55)
ESCI (7)
Scopus (56)
TRDizin (14)
Diğer Yayınlar (3)
2025
20251. Extra intestinal manifestations may increase the risk of synchronous and metachronous development of other extraintestinal manifestations in patients with Crohn’s disease
Ozkahraman A., Kayar Y., Dertli R., Konur S., Kılıc G., Baran B., et al.
Scientific Reports
, cilt.15, sa.1, 2025 (SCI-Expanded)
2025
20252. A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease
İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., İmanov Z., et al.
Scientific Reports
, cilt.15, sa.1, 2025 (SCI-Expanded)
2025
20253. USTEKINUMAB EFFECTIVENESS AND SUSTAINABILITY IN ULCERATIVE COLITIS AND CROHN’S DISEASE
İstemihan Z., Teberik Kama E., Altın S., İmanov Z., Şenkal İ. V., Nurıyev K., et al.
Journal of İstanbul Faculty of Medicine , sa.88, ss.256-263, 2025 (Hakemli Dergi)
2025
20254. Anxiety and Depression Outcomes in Liver Transplant Candidates and Recipients Using the Hospital Anxiety and Depression Scale
Bardak A. E., Cifcibasi Ormeci A., Yildiz Z., Senkal V., Imanov Z., Istemihan Z., et al.
Transplantation Proceedings
, cilt.57, sa.6, ss.1170-1175, 2025 (SCI-Expanded)
2025
20255. The role of GALAD score in the surveillance of hepatocellular carcinoma.
İstemihan Z., Şenkal İ. V., Karaca D., Nurıyev K., Rustamzade A., Genç Uluçeçen S., et al.
Scientific reports
, cilt.15, sa.1, ss.22279, 2025 (SCI-Expanded)
2025
20256. The Role of Pancreatic Enzyme Insufficiency in the Etiology of Functional Dyspepsia Resistant to Standard Treatment
kemik f., CEYLAN G., Aydın A. F., Çavuş B., Ormeci A., Imanov Z., et al.
Turkish Journal of Gastroenterology
, cilt.36, sa.7, ss.467-473, 2025 (SCI-Expanded)
2025
20257. “Liver-Related Mortality in Type 2 Diabetes: Important Insights and Methodological Considerations”
Gurbanov A., Genç Uluçeçen S., Çifçibaşi Örmeci A.
Liver International
, cilt.45, sa.6, 2025 (SCI-Expanded)
2025
20258. Encapsulating Peritoneal Sclerosis: The Consequence of Recurrent Spontaneous Bacterial Peritonitis
Bardak A. E., Selvi B., Poyanlı A., Çifçibaşı Örmeci A.
Digestive Diseases and Sciences
, cilt.70, sa.2, ss.443-444, 2025 (SCI-Expanded)
2025
20259. What are the predictors of malignancy in inflammatory bowel disease?
İstemihan Z., Çavuş B., Bardak A. E., Kirkoğlu A. M., Kiziltaş C., Silay R., et al.
Turkish Journal of Medical Sciences
, cilt.55, sa.4, ss.846-854, 2025 (SCI-Expanded)
2025
202510. Decisional Control Preferences in Managing Intraductal Papillary Mucinous Neoplasms of the Pancreas
Ağargün B. F., Dağcı G., Çavuş B., Çifcibaşı Örmeci A.
Pancreas
, 2025 (SCI-Expanded)
2025
202511. Virological and Biochemical Effects of Tenofovir Alafenamide in Different Patient Groups With Chronic Hepatitis B Virus Infection in Real-World Cohort
Bektas E., Yilmaz A., Kikili C. I., Nuriyev K., Istemihan Z., Senkal I. V., et al.
International Journal of Hepatology
, cilt.2025, sa.1, 2025 (ESCI)
2025
202512. Lumen-apposing metal stents for pancreatic fluid collections: has advancing technology encouraged over-reach?
Ağargün B. F., Cavus B., Cifcibasi Ormeci A., Demir K.
Gut
, 2025 (SCI-Expanded)
2024
202413. Aceruloplasminemia as a rare hereditary disease: four case reports in a single center
İstemihan Z., İmanov Z., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., Beşışık S. F., et al.
Baylor University Medical Center Proceedings , sa.0, ss.1-4, 2024 (Scopus)
2024
202414. Changing Trends in the Etiology of Cirrhosis in Türkiye: A Multicenter Nationwide Study
Üçbilek E., Yıldırım A. E., Ellik Z., Turan İ., Haktanıyan B., Orucu B., et al.
Turkish Journal of Gastroenterology
, cilt.35, sa.10, ss.772-777, 2024 (SCI-Expanded)
2023
202315. Two Cases of Malignant Transformation in Crohn’s Disease with Perianal Involvement
DAĞCI G., VARELCİ S., BÜYÜK M., ÇAVUŞ B., ÇİFCİBAŞI ÖRMECİ A., AKYÜZ F., et al.
Kare Publishing , cilt.2, 2023 (Hakemli Dergi)
2023
202316. Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?
Evirgen S., ÇAVUŞ B., Gokturk S., Iliaz R., ÖZKAN Z. G., Baran B., et al.
Hepatology Forum
, cilt.4, sa.3, ss.103-107, 2023 (Scopus)
2022
202217. Mucocutaneous Manifestations and Associated Factors in Patients with Crohn's Disease
Kayar Y., Dertli R., Konür Ş., Ağın M., Al Kafee A., Baran B., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.33, sa.11, ss.945-954, 2022 (SCI-Expanded)
2022
202218. Different Faces of Eosinophilic Infiltration of Gastrointestinal System
İSTEMİHAN Z., ÇAVUŞ B., BERKER N., Nuriyev K., Şenkal V., İmanov Z., et al.
Journal of Enterocolitis , cilt.1, sa.3, ss.68-71, 2022 (Hakemli Dergi)
2022
202219. What is the effect of subepithelial lesions of the esophagus on esophageal motility?
Oermeci A., Cavus B., Akas R., Istemihan Z., Imanov Z., Senkal V., et al.
European review for medical and pharmacological sciences
, cilt.26, sa.17, ss.6300-6309, 2022 (SCI-Expanded)
2022
202220. Is anterior segment OCT superior to slit-lamp biomicroscopic examination for Kayser Flesicher ring in Wilson's disease?
Ormeci A., Bayraktar S., Isik A. O., Cavus B., Akas R., Istemihan Z., et al.
European review for medical and pharmacological sciences
, cilt.26, sa.14, ss.5178-5185, 2022 (SCI-Expanded)
2022
202221. Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center
Evirgen S., Iliaz R., Akyuz F., Cavus B., Gokturk S., Ormeci A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.6, ss.463-469, 2022 (SCI-Expanded)
2022
202222. Are Hepatobiliary Manifestations Related to the Site of Involvement in Inflammatory Bowel Disease?
İstemihan Z., Çifcibaşı Örmeci A., Çavuş B., Şenkal İ. V., İmanov Z., Nuriyev K., et al.
Journal of Enterocolitis , cilt.1, ss.12-16, 2022 (Hakemli Dergi)
2022
202223. EVALUATION OF HELICOBACTER PYLORI FREQUENCY AND GASTRIC ANTRUM PATHOLOGY FINDINGS IN PATIENTS WITH PORTAL HYPERTENSION
Cavus B., Ormeci A., Evirgen S., Iliaz R., Atasoy A., Yegen G., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.85, sa.2, ss.211-215, 2022 (ESCI)
2022
202224. Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study
BAKKALOĞLU O. K., Yildirim O., Cavus B., Evirgen S., Gokturk S., Ormeci A., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.66, sa.1, 2022 (SCI-Expanded)
2022
202225. A mysterious cause of recurrent acute liver dysfunction for over a decade
Dirim A. B., Kalayci T., Guzel Dirim M., Demir S., Cavus B., Cifcibasi Ormeci A., et al.
GASTROENTEROLOGY REPORT
, cilt.10, 2022 (SCI-Expanded)
2021
202126. The Relationship between Ocular Vascular Changes and the Levels of Malondialdehyde and Vascular Endothelial Growth Factor in Patients with Inflammatory Bowel Disease
Sengul S., Poturoglu S., Samanci C., Ustabasioglu F., Koldas M., Duman A., et al.
OCULAR IMMUNOLOGY AND INFLAMMATION
, cilt.29, sa.7-8, ss.1459-1463, 2021 (SCI-Expanded)
2021
202127. Etiology of Cirrhosis in Turkey: A National Cohort Study
YILDIRIM A. E., ÜÇBİLEK E., Oruncu M. B., TURAN İ., DEMİR M., Koksal A., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded)
2021
202128. ANALYSIS OF GENOTYPE, SUBGENOTYPE AND SEROTYPE OF OCCULT HEPATITIS B VIRUS
Cakal B., Atasoy A., Cavus B., Ormeci A., Poda M., Bulakci M., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.84, sa.3, ss.402-410, 2021 (ESCI)
2021
202129. The development of extraintestinal manifestation and related risk factors in Crohn's patients
Kayar Y., Dertli R., Konur S., Agin M., Baran B., Ormeci A., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.190, sa.2, ss.597-604, 2021 (SCI-Expanded)
2021
202130. What are the predictors for recurrence of Crohn's disease after surgery?
Ozgur İ., Kulle C. B., Buyuk M., Ormeci A., Akyuz F., Balik E., et al.
MEDICINE
, cilt.100, sa.14, 2021 (SCI-Expanded)
2021
202131. Myeloma and Cystoisospora belli REPLY
Tiryaki T. O., Anil K. U., Buyuk M., Yildirim A. Y., Atasoy A., Ormeci A., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.3, ss.230, 2021 (SCI-Expanded)
2021
202132. IMPLICATION OF SERUM IL-17 LEVELS IN CHRONIC HEPATITIS B PATIENTS
ÇAKAL B., ÇAVUŞ B., Atasoy A., Ormeci A., BULAKÇI M., GÜLLÜOĞLU M., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.84, sa.1, ss.68-75, 2021 (ESCI)
2021
202133. Prolonged Severe Watery Diarrhea in a Long-Term Myeloma Survivor: An Unforeseen Infection with Cystoisospora belli
Tiryaki T. O., Anıl K. U., Büyük M., Yıldırım A. Y., Atasoy A., Çiftçibaşı Örmeci A., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.2, ss.171-173, 2021 (SCI-Expanded)
2020
202034. The effect of liver test abnormalities on the prognosis of COVID-19.
Medetalibeyoglu A., Catma Y., Senkal N., Ormeci A., Cavus B., Kose M., et al.
Annals of hepatology
, cilt.19, sa.6, ss.614-621, 2020 (SCI-Expanded, Scopus)
2020
202035. Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period
Akyuz F., Ormeci A., Namazova N., Guzel M., Abbasgoulizadeh A., Tahincioglu L., et al.
JOURNAL OF CROHNS & COLITIS
, 2020 (SCI-Expanded)
2020
202036. Gastroesophageal Reflux in Asymptomatic Patients with Diabetes: An Impedance Study Diabetes, Obesity and Gastroesophageal Reflux
Gokturk S., Akyuz F., Arici S., Alpaslan B., Ormeci A., Soyer O. M., et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
, cilt.128, sa.1, ss.52-58, 2020 (SCI-Expanded, Scopus)
2019
201937. Risk factors associated with progression to intestinal complications of Crohn disease
Kayar Y., Baran B., Ormeci A., Akyuz F., Demir K., Besisik F., et al.
CHINESE MEDICAL JOURNAL
, cilt.132, sa.20, ss.2423-2429, 2019 (SCI-Expanded)
2019
201938. Usage of HCV viremic organs in liver transplantation to anti-HCV negative recipients: The current status and review of literature
ÇİFCİBAŞI ÖRMECİ A., Yildiz C., Seberi B., Gurakar M., Simsek C., Gurakar A.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.30, sa.9, ss.771-775, 2019 (SCI-Expanded)
2019
201939. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?
Akyuz F., Cavus B., Iliaz R., Soyer O. M., Ormeci A., Evirgen S., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.31, sa.7, ss.777-780, 2019 (SCI-Expanded)
2018
201840. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes?
İLIAZ R., AKYÜZ F., Yeğen G., ÖRMECI A., GÖKTÜRK S., AKYÜZ Ü., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.29, sa.4, ss.384-391, 2018 (SCI-Expanded)
2018
201841. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma
Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Evirgen S., et al.
WORLD JOURNAL OF HEPATOLOGY
, cilt.10, sa.1, ss.51-61, 2018 (ESCI)
2017
201742. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts A retrospective cohort study
Soyer O. M., Baran B., Ormeci A., Sahin D., Gokturk S., Evirgen S., et al.
MEDICINE
, cilt.96, sa.1, 2017 (SCI-Expanded)
2016
201643. A rare congenital liver anomaly: Hypoplasia of left hepatic lobe
Ormeci T., Erdogan S. T., ÇİFCİBAŞI ÖRMECİ A., Aygun C.
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
, cilt.66, sa.12, ss.1662-1664, 2016 (SCI-Expanded)
2016
201644. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels
Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M., Pinarbasi B., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
, cilt.52, ss.68-73, 2016 (SCI-Expanded)
2016
201645. Retention during capsule endoscopy: Is it a real problem in routine practice?
Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, cilt.44, sa.4, ss.968-975, 2016 (SCI-Expanded)
2016
201646. Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study
Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., Onel D., et al.
POSTGRADUATE MEDICINE
, cilt.128, sa.4, ss.432-438, 2016 (SCI-Expanded)
2016
201647. Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?
ORMECI A., Emrence Z., BARAN B., SOYER O., GOKTURK S., EVIRGEN S., et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
, cilt.20, sa.9, ss.1795-1797, 2016 (SCI-Expanded)
2016
201648. What is the impact of capsule endoscopy in the long term period?
Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY
, cilt.8, sa.7, ss.344-348, 2016 (ESCI)
2016
201649. Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole
Ormeci A., Emrence Z., Baran B., Gokturk S., Soyer O. M., Evirgen S., et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
, cilt.20, sa.5, ss.879-885, 2016 (SCI-Expanded)
2016
201650. Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection
Ormeci A., Akyuz F., BARAN B., SOYER O., GÖKTÜRK S., ONEL M., et al.
European Review for Medical and Pharmacological Sciences
, cilt.20, sa.5, ss.858-865, 2016 (SCI-Expanded)
2015
201551. Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
LIVER INTERNATIONAL
, cilt.35, sa.10, ss.2265-2274, 2015 (SCI-Expanded)
2014
201452. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening
Demir A., Akyuz F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
, cilt.49, sa.12, ss.1414-1418, 2014 (SCI-Expanded)
2014
201453. Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection
Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
, cilt.12, sa.10, ss.1753-1758, 2014 (SCI-Expanded)
2014
201454. Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma
Karabulut S., Tas F., Akyuz F., Ormeci A., Serilmez M., Soydinc H. O., et al.
TUMOR BIOLOGY
, cilt.35, sa.3, ss.2327-2333, 2014 (SCI-Expanded, Scopus)
2014
201455. Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C
Baran B., Gulluoglu M., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.21, sa.2, ss.111-120, 2014 (SCI-Expanded)
2014
201456. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B
KESKİN O., Ormeci A., Baran B., Kabacam G., Tuzun A., Karatayli E., et al.
ANTIVIRAL THERAPY
, cilt.19, sa.6, ss.543-550, 2014 (SCI-Expanded)
2013
201357. Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors
Demir K., ORMECI A., Emrence Z., Gokturk S., Baran B., SOYER O. M., et al.
GASTROENTEROLOGY
, cilt.144, sa.5, 2013 (SCI-Expanded)
2013
201358. Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Bozbey H. U., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
, cilt.57, sa.4, ss.1790-1796, 2013 (SCI-Expanded)
2013
201359. Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response
Karaca C., Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., et al.
ANTIVIRAL THERAPY
, cilt.18, sa.4, ss.561-566, 2013 (SCI-Expanded)
2012
201260. Treatment of aortic valve stenosis and gastrointestinal bleeding by transcatheter aortic valve implantation in Heyde syndrome
Gul M., Surgit O., Ozal E., Ormeci A., Bakir I.
ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY
, cilt.12, sa.8, ss.691-693, 2012 (SCI-Expanded)
2011
201161. A rare complication of interferon treatment: optic neuropathy
Gokturk S., Atay K., ÇİFCİBAŞI ÖRMECİ A., Baran B., Soyer O. M., AKYÜZ F., et al.
ANNALS OF GASTROENTEROLOGY
, cilt.24, sa.4, ss.335, 2011 (ESCI)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. Steatotic liver disease in diabetic patients: more serious diabetes mellitus, more serious liver disease
İstemihan Z., Bektaş F., Bardak A. E., Kızıltaş C., Kemeç G., Nurıyev K., et al.
EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.551, (Özet Bildiri)
2024
20242. The relationship between spleen stiffness and portal hypertension liver transplant patients
Nurıyev K., İstemihan Z., Telli P., Qurbanov A., Yağlı M. A., Dağcı G., et al.
EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.377-378, (Özet Bildiri)
2024
20243. 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good
İstemihan Z., Kemeç G., Cebeci T., Çetin O., Genç Uluçeçen S., Rüstemzade A., et al.
EASL Congress 2024, Milan, İtalya, 5 - 08 Haziran 2024, ss.803, (Özet Bildiri)
2024
20244. Clinical characteristics of patients with hereditary hemorrhagic telangiectasia: Real-life data, single-center experience
İstemihan Z., Bardak A. E., Nurıyev K., Rüstemzade A., Genç Uluçeçen S., Çavuş B., et al.
ESGE Days 2024, Berlin, Almanya, 25 - 27 Nisan 2024, ss.297, (Özet Bildiri)
2023
20235. Wilson Hastalığında Aile İçi Genetik Taramanın Kliniğe Önemli Katkıları
Şahin A., ÇİFCİBAŞI ÖRMECİ A., SUER İ., DEMİR K., KALAYCI T., ÇEFLE K., et al.
40. Ulusal Gastroenteroloji Haftası ve 11. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 21 - 26 Kasım 2023, (Özet Bildiri)
2023
20236. Otoimmün Tanılı Hastalarda Viral Serolojik Profilin Değerlendirilmesi
Küçükkaya S., Çaklovica Küçükkaya İ., Çavuş B., Safran N., Önel M., Kırkoyun Uysal H., et al.
7. Ulusak Klinik Mikrobiyoloji Kongresi (KLİMUD), Muğla, Türkiye, 1 - 05 Kasım 2023, ss.635, (Özet Bildiri)
2023
20237. ARE THERE NEW PRACTICAL MARKERS TO PREDICT MALIGNANCY IN PANCREATIC CYST FLUIDS?
Anıl K. U., Çavuş B., Çifcibaşı Örmeci A., İmanov Z., Şenkal İ. V., Nurıyev K., et al.
Digestive Disease Week 2023, Washington, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2023, ss.774, (Özet Bildiri)
2022
20228. Tedavi naif ve deneyimli Kronik Hepatit B hastalarında tenofovir alafenamidin gerçek yaşam verileri: daha fazla etki, daha az yan etki
Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.
39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 22 - 27 Kasım 2022, ss.1159-1162, (Özet Bildiri)
2022
20229. HEMOFAGOSİTİK LENFOHİSTİYOSİTOZUN NADİR BİR SEBEBİ: VİSSERAL LEİSHMANİASİS
Yılmaz A., Bektaş E., Bilgin E., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., et al.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.118-119, (Tam Metin Bildiri)
2022
202210. GRANÜLOMATÖZ HEPATİT VE İNTRAHEPATİK KOLESTAZA BAĞLI HİPERLİPİDEMİ İLE SEYREDEN AKCİĞER-DIŞI SARKOİDOZ OLGUSU
Bektaş E., Yılmaz A., Bilgin E., Mutlu Ü., Çavuş B., Çifcibaşı Örmeci A., et al.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.136-137, (Tam Metin Bildiri)
2022
202211. REAL-WORLD DATA OF TENOFOVIR ALAFENAMIDE IN TREATMENT-NAIVE AND EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B: MORE EFFICACY, LESS SIDE EFFECTS
Bektaş E., Yılmaz A., Kıkılı C. İ., Nurıyev K., İstemihan Z., Şenkal İ. V., et al.
AASLD Liver Meeting , District Of Columbia, Amerika Birleşik Devletleri, 4 - 08 Kasım 2022, cilt.76, ss.299, (Özet Bildiri)
2022
202212. Dekompanse karaciğer sirozunda ince barsak tutulumlu diffüz büyük b hücreli lenfoma olgusu
Teberik Kama E., İstemihan Z., Çifcibaşı Örmeci A., Akyüz F., Kaymakoğlu S.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.140, (Özet Bildiri)
2022
202213. İshal ve kilo kaybının nadir bir nedeni:Amiloidoz
Çiftçi A. C., Konyaoğlu H., Şenkal İ. V., Çavuş B., Çifcibaşı Örmeci A., Akyüz F., et al.
21. Çapa Gastroenteroloji Günleri, İstanbul, Türkiye, 31 Mart - 02 Nisan 2022, ss.70, (Tam Metin Bildiri)
2021
202114. Budd-Chiari Sendromu’nda Hepatoselüler Kanser ve Mortalitenin Değerlendirilmesi
İstemihan Z., Nurıyev K., Şenkal İ. V., İmanov Z., Sarıdal M. K., Akas R., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.219, (Özet Bildiri)
2021
202115. Ön Segment Optik Koherans Tomografi (OCT), Wilson hastalığı tanısında Kayser Fleischer Halkası varlığını değerlendirmeki yeri - Ehil oftalmolog gerekliliğine son verecek mi?
Çifcibaşı Örmeci A., Bayraktar Ş., Işık A. O., İstemihan Z., Sarıdal M. K., Akas R., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.218, (Özet Bildiri)
2021
202116. Girişimsel Gastroenterolojik İşlemlerde Hastaların Doktor Tercihinde Cinsiyet Önemli mi?
Kara İnci A., Zaralı S., Akyüz M., İmanov Z., Şenkal İ. V., İstemihan Z., et al.
38. Ulusal Gastroenteroloji Haftası, 9. Gastroenteroloji Cerrahisi Kongresi, Antalya, Türkiye, 16 - 21 Kasım 2021, ss.204, (Tam Metin Bildiri)
2016
201617. COMPARISON OF PROGNOSTIC SCORING SYSTEMS FOR PREDICTION OF SURVIVAL IN HEPATOCELLULAR CARCINOMA
Baran B., Ekinci O., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.
EASL International Liver Congress, Barcelona, İspanya, 13 - 17 Nisan 2016, (Özet Bildiri)
2014
201418. Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors.
Gokturk S., Baran B., Ormeci A., Soyer O., Evirgen S., Ozden I., et al.
Joint International Congress of ILTS, ELITA and LICAGE, London, Kanada, 4 - 07 Haziran 2014, cilt.20, (Özet Bildiri)
2014
201419. Evaluation of Small Bowel Mucosal Damage by Capsule Endoscopy in Familial Mediterranean Fever Patients
Demir A., Besisik F., Gokturk S., Evirgen S., Akyuz U., Ormeci A., et al.
55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2014, cilt.146, (Özet Bildiri)
2014
201420. Is Diabetes Mellitus a Risk Factor for Gastroesophageal Reflux?
Gokturk S., Besisik F., Arici S., Alpaslan B., Ormeci A., Soyer O. M., et al.
55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2014, cilt.146, (Özet Bildiri)
2014
201421. ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Kanada, 9 - 13 Nisan 2014, (Özet Bildiri)
2013
201322. Baseline alfa-fetoprotein level is a strong predictor of vascular invasion and survival in patients with hepatocellular carcinoma
Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Poyanli A., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
201323. Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels
Ormeci A., Akyuz F., Baran B., Soyer O. M., Gokturk S., Karaca C., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)
2013
201324. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)
2013
201325. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus
Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)
2013
201326. Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection
Gokturk S., Basar R., Ucar A. R., Basgoze B. H., Altinkaynak M., Buyukballi P., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
201327. Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B
Akyuz F., Gokturk S., Baran B., Ormeci A., Soyer O. M., Evirgen S., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
201328. IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis
Karaca C., Yilmaz E., Soyer O. M., Onel D., ÖNEL M., Baran B., et al.
Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, Amerika Birleşik Devletleri, 18 - 21 Mayıs 2013, cilt.144, (Özet Bildiri)
2013
201329. Does Chemoprophylaxis Prevent Tuberculosis Reactivation in the Long Term Period of Anti-TNF Treatment?
AKYÜZ F., Soyer O. M., Gokturk S., ÇİFCİBAŞI ÖRMECİ A., Evirgen S., Onder S. Y., et al.
Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Florida, Amerika Birleşik Devletleri, 18 - 21 Mayıs 2013, cilt.144, (Özet Bildiri)
2013
201330. TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C
Baran B., Gulluoglu M., Soyer O., Ormeci A., Gokturk S., Evirgen S., et al.
International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, (Özet Bildiri)
2012
201231. Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients
Baran B., Ozcan E., Oztop N., Cakmak R., Soyer O. M., Ormeci A., et al.
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56, (Özet Bildiri)
2012
201232. Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b
KESKİN O., Ormeci A., Kabacam G., Akyuz F., Aniktar H., Karaca C., et al.
63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56, (Özet Bildiri)
2012
201233. Success of Two Different Endoscopic Submucosal Resection Methods in Gastric Subepithelial Lesions
Karaca C., Soyer O. M., Akyuz F., Baran B., Ormeci A., Gokturk S., et al.
Digestive Disease Week (DDW), California, Amerika Birleşik Devletleri, 19 - 22 Mayıs 2012, cilt.75, ss.136, (Özet Bildiri)
2012
201234. RESPONSE TO TENOFOVIR TREATMENT OF TREATMENT-NAIVE VS ADEFOVIR-RESISTANT VS SUBOPTIMAL RESPONDER PATIENTS WITH CHRONIC HEPATITIS B
Keskin O., Ormeci A., Kabacam G., Akyuz F., Aniktar H., Karaca C., et al.
47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, İspanya, 18 - 22 Nisan 2012
Bilimsel Dergilerdeki Faaliyetler
2021 - Devam Ediyor
2021 - Devam EdiyorJournal of Enterocolitis
Yardımcı Editör/Bölüm Editörü
2019 - Devam Ediyor
2019 - Devam EdiyorHepatology Forum
Yardımcı Editör/Bölüm Editörü